FrostPharma

FrostPharma is a pharmaceutical company focusing on specialty medicines that meet specific needs for healthcare, patients, and society. Since its founding in 2017, the company has successfully commercialized a large portfolio of value-adding medicines (+60 products) across multiple therapeutic areas throughout the Nordics and the Baltics. The key to this success is FrostPharma's ability to match specific needs in healthcare with relevant products that make a difference, and to leverage its expertise in sales and marketing to rapidly generate commercial impact. In 2024, FrostPharma acquired the pharmaceutical company Abboxia, adding several proprietary products to the portfolio. FrostPharma has around 40 employees and its headquarters are in Stockholm.